Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • HESmith
    Senior Member
    • Oct 2009
    • 512

    #1

    proper normalization of ChIP-Seq data

    We're comparing a histone modification in control samples vs. experimental samples in which the modifying enzyme is overexpressed. Western blotting indicates ~3X increase in the amount of modified histones, and qPCR of ChIPed material shows a similar increase for known target sites. Comparison of ChIP-Seq data sets indicate that the distribution of the modification is unchanged (i.e., the same peaks are detected in control and experiment). This result was anticipated by other experiments, so nothing earth-shattering.

    The question: what is the appropriate method/algorithm for normalizing the ChIP-Seq data that demonstrates the enrichment we observe at these identical peaks? Most of the available tools seem designed for detecting different peaks, using the same (normalized) number of reads. In our case, however, such normalization essentially suppresses the difference in magnitude we detect by the other methods.

    I'd appreciate suggestions from the more statistically-savvy members of the community.

    Thanks,
    Harold
    Last edited by HESmith; 05-24-2013, 12:17 PM. Reason: clarification
  • aurélie teissandier
    Junior Member
    • Sep 2012
    • 1

    #2
    Hi Harold,

    I have the same problem. Do you have an answer to your question? Which method do you use to compare your different samples?

    Thanks
    Aurélie

    Comment

    • mknut
      Member
      • Jul 2012
      • 23

      #3
      To investigate differences between peaks at the same positions I use DiffBind. It looks like you have already done peak occupancy analysis, the next step would be binding affinity analysis. Binding affinity analysis is basically investigation of differences in enrichment at same peaks across different samples - seems to be exactly what you are after. DiffBind is an R package and is actually quite easy to use and does not require a lot of expertise in R.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      27 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      20 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      43 views
      0 reactions
      Last Post SEQadmin2  
      Working...